DEFERASIROX
deferasirox 125 mg dispersible tablet, 28
DEFERASIROX (5654N)
5654N
Body System:
Manner of administration:Oral
Restriction (Streamlined authority code: 8328)
Indication: Chronic iron overload
Treatment phase: Continuing treatment
Restriction (Streamlined authority code: 8329)
Indication: Chronic iron overload
Treatment phase: Continuing treatment
Restriction (Streamlined authority code: 8326)
Indication: Chronic iron overload
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 6 | Max qty units: 168 | # of repeats: 2 | DPMQ: $593.70 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||